• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Fecal calprotectin: A promising readily available tool associated with outcome in patients with cirrhosis.粪便钙卫蛋白：一种有前景的、易于获取的与肝硬化患者预后相关的工具。
United European Gastroenterol J. 2025 Apr;13(3):349-350. doi: 10.1002/ueg2.12640. Epub 2024 Nov 1.
2
Fecal calprotectin is a useful screening parameter for hepatic encephalopathy and spontaneous bacterial peritonitis in cirrhosis.粪便钙卫蛋白是肝硬化肝性脑病和自发性细菌性腹膜炎的有用筛查参数。
Liver Int. 2011 Oct;31(9):1406-15. doi: 10.1111/j.1478-3231.2011.02577.x.
3
The role of fecal calprotectin in assessment of hepatic encephalopathy in patients with liver cirrhosis.粪便钙卫蛋白在肝硬化患者肝性脑病评估中的作用
Acta Gastroenterol Belg. 2014 Sep;77(3):302-5.
4
Elevated calprotectin levels are associated with mortality in patients with acute decompensation of liver cirrhosis.血清钙卫蛋白水平升高与肝硬化急性失代偿患者的死亡率相关。
World J Hepatol. 2022 Nov 27;14(11):1964-1976. doi: 10.4254/wjh.v14.i11.1964.
5
Fecal calprotectin in patients with liver cirrhosis.肝硬化患者的粪便钙卫蛋白
Indian J Gastroenterol. 2023 Dec;42(6):818-823. doi: 10.1007/s12664-023-01450-9. Epub 2023 Oct 12.
6
[Elevated concentrations of fecal calprotectin in patients with liver cirrhosis].[肝硬化患者粪便钙卫蛋白浓度升高]
Dtsch Med Wochenschr. 2006 Sep 8;131(36):1930-4. doi: 10.1055/s-2006-949189.
7
Faecal cytokine profiling as a marker of intestinal inflammation in acutely decompensated cirrhosis.粪便细胞因子谱作为急性失代偿期肝硬化肠道炎症的标志物
JHEP Rep. 2020 Dec;2(6):100151. doi: 10.1016/j.jhepr.2020.100151. Epub 2020 Jul 30.
8
Fecal calprotectin levels predict colorectal inflammation among patients with chronic diarrhea referred for colonoscopy.粪便钙卫蛋白水平可预测因慢性腹泻接受结肠镜检查患者的结肠炎症。
Am J Gastroenterol. 2000 Oct;95(10):2831-7. doi: 10.1111/j.1572-0241.2000.03194.x.
9
Efficacy of Fecal Calprotectin Combined With Stool Hemoglobin in Differentiating Bacterial Origin in Acute Gastroenteritis.粪便钙卫蛋白联合粪便血红蛋白检测对急性肠炎细菌来源的鉴别诊断价值
Pediatr Emerg Care. 2022 Feb 1;38(2):e670-e673. doi: 10.1097/PEC.0000000000002414.
10
Systematic review of the role of calprotectin in cirrhosis.系统评价钙卫蛋白在肝硬化中的作用。
Eur J Clin Invest. 2024 Feb;54(2):e14111. doi: 10.1111/eci.14111. Epub 2023 Oct 17.

本文引用的文献

1
Assessment of intestinal inflammation via fecal calprotectin for early prediction of adverse outcomes in advanced chronic liver disease.通过粪便钙卫蛋白评估肠道炎症以早期预测晚期慢性肝病的不良结局
United European Gastroenterol J. 2025 Apr;13(3):305-316. doi: 10.1002/ueg2.12633. Epub 2024 Jul 19.
2
One - or more - blind spot(s) unveiled in the new definition of decompensated cirrhosis.失代偿期肝硬化新定义中揭示的一个或多个盲点。
J Hepatol. 2024 Apr;80(4):537-539. doi: 10.1016/j.jhep.2024.01.039. Epub 2024 Feb 8.
3
Toward a more precise prognostic stratification in acute decompensation of cirrhosis: The Padua model 2.0.迈向更精准的肝硬化急性失代偿期预后分层：帕多瓦模型 2.0。
United European Gastroenterol J. 2023 Nov;11(9):815-824. doi: 10.1002/ueg2.12472. Epub 2023 Oct 4.
4
Severity of systemic inflammation is the main predictor of ACLF and bleeding in individuals with acutely decompensated cirrhosis.全身炎症的严重程度是急性失代偿性肝硬化患者发生慢加急性肝衰竭和出血的主要预测指标。
J Hepatol. 2023 Feb;78(2):301-311. doi: 10.1016/j.jhep.2022.09.005. Epub 2022 Sep 21.
5
The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology.PREDICT研究揭示了急性失代偿性肝硬化的三种具有不同病理生理学特征的临床病程。
J Hepatol. 2020 Oct;73(4):842-854. doi: 10.1016/j.jhep.2020.06.013. Epub 2020 Jul 13.
6
Accuracy of calprotectin using the Quantum Blue Reader for the diagnosis of spontaneous bacterial peritonitis in liver cirrhosis.使用量子蓝读数仪检测钙卫蛋白对肝硬化患者自发性细菌性腹膜炎的诊断准确性
Hepatol Res. 2019 Jan;49(1):72-81. doi: 10.1111/hepr.13239. Epub 2018 Sep 4.
7
Clinical states of cirrhosis and competing risks.肝硬化的临床状态和竞争风险。
J Hepatol. 2018 Mar;68(3):563-576. doi: 10.1016/j.jhep.2017.10.020. Epub 2017 Oct 27.
8
The CLIF Consortium Acute Decompensation score (CLIF-C ADs) for prognosis of hospitalised cirrhotic patients without acute-on-chronic liver failure.CLIF 联盟急性失代偿评分（CLIF-C ADs）用于预测无慢加急性肝衰竭的住院肝硬化患者的预后。
J Hepatol. 2015 Apr;62(4):831-40. doi: 10.1016/j.jhep.2014.11.012. Epub 2014 Nov 22.
9
Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis.急性慢性肝衰竭是一种独特的综合征，发生在肝硬化急性失代偿的患者中。
Gastroenterology. 2013 Jun;144(7):1426-37, 1437.e1-9. doi: 10.1053/j.gastro.2013.02.042. Epub 2013 Mar 6.
10
Plasma calprotectin: a new prognostic marker of survival in alcohol-induced cirrhosis.血浆钙卫蛋白：酒精性肝硬化生存的一种新的预后标志物。
Hepatology. 1995 Apr;21(4):979-85.

Fecal calprotectin: A promising readily available tool associated with outcome in patients with cirrhosis.

作者信息

Artru Florent

机构信息

Liver Department, Rennes University Hospital, Rennes, Bretagne, France.

NuMeCan Institute, Inserm U1241, Rennes Liver Failure Group (RELIEF), University of Rennes, Rennes, Bretagne, France.

出版信息

United European Gastroenterol J. 2025 Apr;13(3):349-350. doi: 10.1002/ueg2.12640. Epub 2024 Nov 1.

DOI:10.1002/ueg2.12640
PMID:39484801
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11999036/
Abstract
摘要